There's a new source of funding for life sciences companies in town, providing credit as an alternative to other financing avenues such as venture capital.
Ursula von der Leyen has been re-elected as president of the European Commission following a secret ballot in the European Parliament and, among the pledges made during her speech before th
Amgen has chalked up a victory in a patent infringement lawsuit with Regeneron over blockbuster ophthalmic drug Eylea and decided to launch its biosimilar in the US – even though the legal